(Date:11/23/2009)..., CT Current research suggests that a common oral... related report by Nichols et al, "Unique Lipids f... of TLR2 Ligands Capable of Enhancing Autoimmunity...ican Journal of Pathology . , Multiple sclerosis...he brain and spinal cord, affects nearly 1 in 700 ...
(Date:11/23/2009)...wa - The only swine vaccine available for the H1N1...ected with the virus. The vaccination marks the fi...gnosed with the pandemic flu., Iowa State Univer...eveloped the vaccine this summer and has been ship...Kansas and Illinois for several weeks., The late...
(Date:11/23/2009)...I, November 16, 2009 -- A USDOE and USDA study con...e cropland, and cropland pasture could be converte... grasses, such as switchgrass, from which biomass ... Economically viable production of a perennial gra...f biomass are removed annually is expected to requ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 1McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 2McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 3Cost Savings Adds to Value of Preventing Chronic Disease 58165 1Cost Savings Adds to Value of Preventing Chronic Disease 58165 2US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 1US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 2US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 3(Date:11/24/2009)...LE,Nov.24/PRNewswire-FirstCall/--CellTherapeutics,...tthe21stAnnualPiperJaffrayHealthCareConference.The...alaceHotel. ,, CTIwillpresentonTuesday,December...diowebcastofCTI,spresentationwillbeavailableat www...replayafterwards. , ,PiperJaffrayHealthCareConfer...
(Date:11/23/2009)...NEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBi...NASDAQhasestablishedNovember27,2009astheex-dividen...sresultingfromthesecuritizationtransactioncomplete...5,2009toallstockholdersofrecordontherecorddate,Dec...ntofthedividendat$1.67pershareofcommonstockforpurp...
(Date:11/23/2009)...BY,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc...h.DasitsPresidentandCEO. ,, Abramsbringsmoretha...nimex.Heisaco-inventorofthenuclearmedicineimaginga...tthey,plcwherehewasManager,BiomedicalResearchWorld...ngley,BCandwasPresidentandCEOfrom1996to2006.AnorME...
(Date:11/20/2009)...atin American countries have an opportunity to tak...earchers from the University of Valencia (UV), wor...udied the productive fabric of the Spanish biotech...food and plant sectors have more clout than those ...s applied to food and plants has been overlooked b...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2...e in Adoption of Incisionless Natural Orifi...LEMENTE, Calif., Dec. 19 USGI Medical, Inc., the,...ry, today announced that,its EndoSurgical Operatin...to effectively close a gastrotomy (an incision in ...US. Leading surgeons demonstrated the gastrotomy,c...
...ive license,for the development and commercialisat...in Cystic Fibrosis patients was signed today. As p... Japan transferred relevant,rights to Axentis Phar...,orphan drug status to the licensed technology and...entis Pharma AG in early 2008., Axentis Pharma AG...
...ionise the transformation of solar energy to elect...t from solar electricity and save money in the fut... cells meet the expectations, both your economy an...Less than 1 per cent of the worlds electricity com...rm solar energy to electricity. But Martin Aagesen...
Other Biology Technology:USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES 2Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections 2Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections 3Mouse Anti-EGFr VIII Antibody, Unconjugated from Invitrogen
Custom siRNA, PAGE purified from Ambion
GIBCO Kanamycin Sulfate from Invitrogen
Silencer Pre-designed siRNA, standard purity from Ambion
Biology Products: